Abstract:Background: Most people are infected with COVID-19 during pandemics at the end of 2022. Older patients were more vulnerable. However, the incidence of secondary bacterial, fungal or viral pulmonary infection and co-infection is not well described in elderly hospitalized COVID-19 patients. Methods: We retrospectively reviewed the medical records of all elderly (≥65 years) hospitalized patients with laboratory-confirmed COVID-19 from December 1, 2022 to January 31, 2023. Demographics, underlying diseases, treatments, and laboratory data were collected. Univariate and multivariate logistic regression models were used to explore the risk factors associated with secondary bacterial, fungal or viral pulmonary infection and co-infection. Results: A total of 322 older patients with COVID-19 were enrolled. The incidence of secondary bacterial, fungal or viral pulmonary infection and co-infection was 27.3% (88/322) and 7.5% (24/322), respectively. The overall in-hospital mortality of all patients was 32.9% (106/322), and the in-hospital mortality among patients who acquired with secondary pulmonary infection and co-infection was 57.0% (57/100). A total of 23.9% (77/322) of patients were admitted to ICU within 48 h of hospitalization. The incidence of secondary pulmonary infection and co-infection among patients admitted to the ICU was 50.6% (39/77) and 13.0% (10/77), respectively. The overall in-hospital mortality of ICU patients was 48.1% (37/77), and the in-hospital mortality of ICU patients acquired with secondary pulmonary infection and co-infection was 61.4% (27/44). A total of 83.5% (269/322) of the included patients received empirical antibiotic therapy before positive Clinical Microbiology results. Influenza A virus (the vast majority were the H3N2 subtype) was the most common community acquired pathogen for co-infection. While A. baumannii, K. pneumoniae, and P. aeruginosa were the common hospital acquired pathogens for co-infection and secondary pulmonary infection. The incidence of Carbapenem-resistant Gram-negative bacilli (CR-GNB) infections was high, and the mortality reached 76.9%. Predictors of secondary pulmonary infection and co-infection were ICU admission within 48 h of hospitalization, cerebrovascular diseases, critical COVID-19, and PCT > 0.5 ng/mL. Conclusion: The prognosis for elderly hospitalized COVID-19 patients with secondary pulmonary infection or co-infection is poor. The inflammatory biomarker PCT > 0.5 ng/mL played an important role in the early prediction of secondary pulmonary infection and co-infection in COVID-19 patients.

[Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19].

COVID-19 Associated Cerebral Infarction in an Elderly Patient: A Case Report

A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis

Diagnosis and treatment of craniocerebral injury in elderly people

Coagulation Dysfunction In Icu Patients With Coronavirus Disease 2019 In Wuhan, China: A Retrospective Observational Study Of 75 Fatal Cases

The Experience of Diagnosis and Treatment of Neurological Diseases Combined with Coronavirus Disease 2019: Analysis of Five Cases

Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report

Concurrent Cerebral, Splenic, and Renal Infarction in a Patient With COVID-19 Infection

The clinical characteristics and prognosis of COVID‐19 patients with cerebral stroke: A retrospective study of 113 cases from one single‐centre

Ischemic Necrosis of Lower Extremity in COVID-19: A Case Report

Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literature

Case report: unprecedented case of infantile cerebral infarction following COVID-19 and favorable outcome

Secondary pulmonary infection and co-infection in elderly COVID-19 patients during the pandemics in a tertiary general hospital in Beijing, China

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

[Experts Consensus for the Diagnosis, Treatment, and Prevention of Coronavirus Disease 2019 in the Elderly].

COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report

Case report: cerebral thromboembolism in an unconscious COVID-19 patient in intensive care

Coronavirus disease 2019 and acute cerebrovascular events: a comprehensive overview

Acute Ischemic Stroke as Complication in COVID-19 with Acute Respiratory Distress Syndrome in Intensive Care Unit: A Review

Splenic abscess secondary to COVID-19 acute infection: A case report and literature review

Factors Affecting Mortality in Elderly Hypertensive Hospitalized Patients with COVID-19: A Retrospective Study